DarioHealth Corp. (DRIO)

NASDAQ: DRIO · Real-Time Price · USD
0.780
-0.020 (-2.49%)
Dec 23, 2024, 10:38 AM EST - Market open
-2.49%
Market Cap 26.60M
Revenue (ttm) 23.05M
Net Income (ttm) -32.30M
Shares Out 34.10M
EPS (ttm) -0.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 68,848
Open 0.790
Previous Close 0.800
Day's Range 0.690 - 0.820
52-Week Range 0.650 - 2.600
Beta 1.41
Analysts Strong Buy
Price Target 4.00 (+412.76%)
Earnings Date Nov 7, 2024

About DRIO

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, wh... [Read more]

Sector Healthcare
Founded 2011
Employees 294
Stock Exchange NASDAQ
Ticker Symbol DRIO
Full Company Profile

Financial Performance

In 2023, DarioHealth's revenue was $20.35 million, a decrease of -26.41% compared to the previous year's $27.66 million. Losses were -$54.86 million, -8.50% less than in 2022.

Financial Statements

Analyst Forecast

According to one analyst, the rating for DRIO stock is "Strong Buy" and the 12-month stock price forecast is $4.0.

Price Target
$4.0
(412.76% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Dario Signs Four New Employer Contracts Across Full Product Suite

Company expects to reach an estimated total of 25 new client signings in 2024, representing an approximate 35% growth in client base compared to 2023 NEW YORK , Nov. 21, 2024 /PRNewswire/ -- DarioHeal...

4 weeks ago - PRNewsWire

DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript

DarioHealth Corp. (NASDAQ:DRIO) Q3 2024 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steve...

6 weeks ago - Seeking Alpha

DarioHealth Reports Third Quarter 2024 Financial and Operating Results

Demonstrated strong improvements in financial performance and business momentum. Q3 revenue of $7.42 million increased 18.7% over Q2 2024 and 111% compared to Q3 2023, driven by expansion of B2B2C rev...

6 weeks ago - PRNewsWire

Dario Expands Pharma Collaborations with Global Pharma Leader to Enhance User Engagement

The new platform services subscription contract with a top six U.S. pharma client marks a pivotal shift in Dario's pharma channel, transitioning the business model from milestone-based to recurring se...

7 weeks ago - PRNewsWire

Dario Signs New Regional Health Plan, Expanding Reach in Medicaid Population

The new contract marks the eighth health plan for Dario and will contribute to revenues starting immediately. NEW YORK , Oct. 30, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the ...

7 weeks ago - PRNewsWire

DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th

Company to host conference call and webcast at 8:30am ET NEW YORK , Oct. 23, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a global leader in digital health, announ...

2 months ago - PRNewsWire

Dario Announces Complete Integration of Twill Capabilities Across Full Multi-Condition Platform

Integration of behavioral health and wellbeing solutions with navigation and engagement technology creates the most comprehensive solution in the market under the Dario brand NEW YORK , Oct. 17, 2024 ...

2 months ago - PRNewsWire

Twill by Dario to Offer a Benefit for AARP Members

New offer gives Dario access to millions of AARP members, enabling engagement with people over 50 in health and well-being beginning in January 2025 NEW YORK , Oct. 15, 2024 /PRNewswire/ -- DarioHealt...

2 months ago - PRNewsWire

National Medicare Health Plan Partners with Twill by Dario to Promote Healthy Aging with New Digital Mental Health Benefits for Seniors

The new contract significantly expands Dario's footprint with more than a million eligible members beginning January 2025 NEW YORK , Oct. 1, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dar...

2 months ago - PRNewsWire

DarioHealth And 2 Other Stocks Under $5 Executives Are Buying

The Dow Jones index closed higher by more than 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.

3 months ago - Benzinga

Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes

The integration of Twill's condition-specific, expert-led peer groups will enhance the member experience and deepen engagement with Dario's proven cardiometabolic solution NEW YORK , Sept. 12, 2024 /P...

3 months ago - PRNewsWire

Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes

New Research Confirms the Benefit of Dario's Integrated, Data-Driven Approach to Health and Chronic Condition Management NEW YORK , Sept. 10, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Da...

3 months ago - PRNewsWire

DarioHealth Corp. (DRIO) Q2 2024 Earnings Call Transcript

DarioHealth Corp. (NASDAQ:DRIO) Q2 2024 Results Conference Call August 8, 2024 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven ...

4 months ago - Seeking Alpha

DarioHealth Reports Second Quarter 2024 Financial and Operating Results

Q2 revenue of $6.26 million reflects an increase of 8.6% over Q1 2024, and an increase of 1.7% over Q2 of 2023, driven primarily by increased B2B2C revenues Q2 commercial and consumer revenues totaled...

4 months ago - PRNewsWire

DarioHealth to Report Second Quarter 2024 Results on Thursday, August 8th

Company to host conference call and webcast at 8:30am ET NEW YORK , July 30, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced ...

5 months ago - PRNewsWire

Dario Expands GLP-1 Solution Client Base with New Employer Contract

Dario's leading behavior change solutions continue to win interest in the employer, payer and pharmaceutical markets NEW YORK , July 16, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" ...

5 months ago - PRNewsWire

Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1

New research confirms behavior change driven by Dario digital platform is sustainable for 12 month period and supports clinical results for members taking a GLP-1 Additional research demonstrates 31% ...

6 months ago - PRNewsWire

Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer

After two decades of successfully scaling multiple healthcare companies, Steven Nelson joins DarioHealth as Chief Commercial Officer to accelerate revenue growth across the health plans, employers and...

7 months ago - PRNewsWire

DarioHealth Corp. (DRIO) Q1 2024 Earnings Call Transcript

DarioHealth Corp. (NASDAQ:DRIO) Q1 2024 Earnings Conference Call May 15, 2024 8:30 AM ET Company Participants Kat Parrella - IR Erez Raphael - CEO Rick Anderson - President Conference Call Participan...

7 months ago - Seeking Alpha

DarioHealth Reports First Quarter 2024 Financial and Operating Results

First quarter revenue of $ 5.8 million reflects an increase of 59% over fourth quarter of 2023 primarily resulting from an increase in B2B2C revenues and reflects a decrease of 18.5% compared to the f...

7 months ago - PRNewsWire

DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th

Company to host conference call and webcast at 8:30am ET NEW YORK , May 7, 2024 /PRNewswire/ --  DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced t...

8 months ago - PRNewsWire

Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes

Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solution for members to manage diabetes, pre-diabetes, blood pressure, weight and taking a GLP-1 NEW YORK , ...

8 months ago - PRNewsWire

Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution

Dario selected to provide integrated and proven solutions to improve employee cardiometabolic health NEW YORK , April 18, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company...

8 months ago - PRNewsWire

Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health

Studies include a Randomized Controlled Trial demonstrating significant reduction in perceived stress for teens NEW YORK , April 10, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or t...

9 months ago - PRNewsWire

Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health

Dario selected to provide integrated approach to improve employee cardiometabolic health - including support for those taking a GLP-1 medication - musculoskeletal and behavioral health NEW YORK , Apri...

9 months ago - PRNewsWire